Rafferty Asset Management, LLC Beam Therapeutics Inc. Transaction History

Rafferty Asset Management, LLC

  • $29.4 Billion
  • Q2 2025

A detailed history of Rafferty Asset Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 122,832 shares of BEAM stock, worth $3.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
122,832
Previous 119,871 2.47%
Holding current value
$3.28 Million
Previous $2.34 Million 10.76%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$14.54 - $20.24 $43,052 - $59,930
2,961 Added 2.47%
122,832 $2.09 Million
Q1 2025

May 14, 2025
BUY
$19.53 - $34.09 $171,297 - $299,003
8,771 Added 7.89%
119,871 $2.34 Million
Q4 2024

Feb 14, 2025
SELL
$21.55 - $30.35 $1.64 Million - $2.31 Million
-75,991 Reduced 40.62%
111,100 $2.76 Million
Q3 2024

Nov 13, 2024
BUY
$22.57 - $33.14 $492,635 - $723,346
21,827 Added 13.21%
187,091 $4.58 Million
Q2 2024

Aug 13, 2024
SELL
$21.22 - $32.66 $1.68 Million - $2.58 Million
-79,090 Reduced 32.37%
165,264 $3.87 Million
Q1 2024

May 13, 2024
SELL
$23.46 - $45.07 $2.24 Million - $4.3 Million
-95,363 Reduced 28.07%
244,354 $8.07 Million
Q4 2023

Feb 13, 2024
SELL
$17.69 - $30.76 $7,500 - $13,042
-424 Reduced 0.12%
339,717 $9.25 Million
Q3 2023

Nov 13, 2023
BUY
$23.01 - $32.46 $1.89 Million - $2.67 Million
82,150 Added 31.84%
340,141 $8.18 Million
Q2 2023

Aug 11, 2023
BUY
$29.32 - $35.99 $1.36 Million - $1.67 Million
46,323 Added 21.88%
257,991 $8.24 Million
Q1 2023

May 11, 2023
BUY
$30.15 - $48.79 $510,831 - $826,648
16,943 Added 8.7%
211,668 $6.48 Million
Q4 2022

Feb 13, 2023
BUY
$36.73 - $51.6 $2.6 Million - $3.65 Million
70,800 Added 57.13%
194,725 $7.62 Million
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $117,460 - $207,555
2,952 Added 2.44%
123,925 $5.9 Million
Q2 2022

Aug 12, 2022
BUY
$29.86 - $62.36 $913,417 - $1.91 Million
30,590 Added 33.84%
120,973 $4.68 Million
Q1 2022

May 13, 2022
BUY
$53.73 - $82.16 $892,132 - $1.36 Million
16,604 Added 22.51%
90,383 $5.18 Million
Q4 2021

Feb 10, 2022
BUY
$68.02 - $99.06 $3.07 Million - $4.47 Million
45,173 Added 157.91%
73,779 $5.88 Million
Q3 2021

Nov 10, 2021
SELL
$84.37 - $133.6 $66,146 - $104,742
-784 Reduced 2.67%
28,606 $2.49 Million
Q2 2021

Aug 10, 2021
SELL
$64.12 - $128.71 $286,231 - $574,561
-4,464 Reduced 13.19%
29,390 $3.78 Million
Q1 2021

May 10, 2021
BUY
$71.28 - $120.75 $1.64 Million - $2.78 Million
23,029 Added 212.74%
33,854 $2.71 Million
Q4 2020

Feb 10, 2021
BUY
$22.24 - $95.63 $240,747 - $1.04 Million
10,825 New
10,825 $884,000

Others Institutions Holding BEAM

# of Institutions
246
Shares Held
95.8M
Call Options Held
666K
Put Options Held
1.99M
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.88B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email